Geneva, April 28 -- International Clinical Trials Registry received information related to the study (TCTR20260416001) titled 'Effect of intravenous hydrocortisone in in-hospital acquire sepsis: a randomized control trial' on April 16.
Study Type: Interventional
Study Design:
Randomized
Primary Sponsor: Faculty of Medicine Siriraj Hospital, Mahidol University
Condition:
In-hospital acquired sepsis
Septic shock
Hypotension
Hydrocortisone
Corticosteroids
Critical illness
Adrenal insufficiency
Diabetes mellitus
Personalized medicine
Hydrocortisone
Corticosteroids
Critical illness
Adrenal insufficiency
Diabetes mellitus
Personalized medicine
Intervention:
Patients will receive a 50 mg intravenous bolus of hydrocortisone every 6 hours...